[rev_slider alias=”home-031″]

DR Healthcare has launched an awareness campaign on DAO Deficiency under the title ME AGAIN. In it, four siblings discover that the different symptoms that affect them: migraine, fibromyalgia, digestive disorders, atopic skin and ADHD (in the son of one of them), may have a common genetic origin in DAO Deficiency.

You can access the videos and the content of the campaign by clicking on the following button.

DR Healthcare

We are a Biomedical Company specialized in Medical Nutrition.

Founded in 2007 in Barcelona, ​​we manufacture, research, develop, innovate, market and carry out licensing -out of new nutraceutical products, functional foods, active ingredients and customized solutions.

Our great value is research and we firmly believe in the “Enterprise-University” alliance, developing our activities in two R&D centers.

DR Healthcare is a business unit de AB Biotek. For more information access to www.abbiotek.com

SGS-ISO 9001-COLOR
SGS-ISO 14001-COLOR

Manufacturing for third parties

DR Healthcare manufactures and markets the active substance (Diamine Oxidase – DAO enzyme) for third parties, both for human and animal use.

We make available to pharmaceutical and food companies that are looking for a reliable supplier, the highest levels of quality, regulatory support and production of Diamine Oxidase, manufactured in our enzyme production plant located in Tarragona (Spain).

The production of this ADI (Active Dietary Ingredient) is vertically integrated so it is able to control the intermediates of its manufacturing.

Customized solutions

DR Healthcare stands out as a leading company in the production of Diamino Oxidasa, which allows us to offer tailored solutions for use in the veterinary, animal health and food sectors.

Our solutions based on Diamino Oxidase are adapted to the new food control standards, which stipulate the control of histamine levels in order to avoid risks of poisoning due to the consumption of large amounts of this biogenic amine present in food.

 

Actuality

Press releases and media’s news

New Regulatory Approvals Support DAO Deficiency Solution Expansion

In February 2022, the active ingredient diamine oxidase – or DAO – produced by AB Biotek’s DR Healthcare division, as well as the solutions derived from it, have obtained the GRAS (Generally Recognized As Safe, per sections 201(s) and 409 of the U.S. Food & Drug Act) qualification from the U.S. Food & Drug Administration.  This allows for the upcoming...

Scientific and clinical evidence in DAO deficiency

Serum levels of histamine and diamine oxidase in multiple sclerosis

Serum levels of histamine and diamine oxidase in multiple sclerosis Download pdf   Am J Clin Exp Immunol 2018;7(6):100-105 www.ajcei.us /ISSN:2164-7712/AJCEI0086352 Aryan Rafiee Zadeh1, Masih Falahatian1, Fereshteh Alsahebfosoul2 1School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran; 2Department of Immunology, School of Medicine, Isfahan University...

 Blog

The histamine interposes at Christmas

Histamine accumulation in the body due to excessive food and alcohol consumption causes gastrointestinal disorders, headaches and migraine. The International Society of DAO Deficiency recommends moderating the intake of food, especially those rich in histamine such as cured meat, smoked products, seafood and typical Christmas dessert, and supplement menu with DAO...

Activities and events

The food origin of migraine as a result of Diamine Oxidase (DAO) enzyme deficiency

3rd International Conference and Exhibition on Nutrition & Food Sciences. September 2014, Valencia Convention Centre, Spain. Adriana Duelo, International Society of DAO Deficiency, Spain. Journal Nutritional Food Sci, 2014 Volume 4, Issue 5, page 54.
St/Escoles Píes, 49, 08017
DR HEALTHCARE ESPAÑA, S.L. (Barcelona, Spain)